Correlation of intestinal flora with serum glucagon-like peptide-1 level in patients with nonalcoholic fatty liver disease

Correlation of intestinal flora with serum glucagon-like peptide-1 level in patients with nonalcoholic fatty liver disease

ObjectiveTo investigate the correlation of intestinal dysbacteriosis with serum glucagon-like peptide-1 (GLP-1) level in patients with nonalcoholic fatty liver disease (NAFLD). MethodsA total of 116 patients with NAFLD who attended Wuhan Hankou Hospital from January to December 2018, were enrolled a...

Full description

Bibliographic Details
Main Author:	LIU Zhiping
Format:	Article
Language:	zho
Published:	Editorial Department of Journal of Clinical Hepatology 2020-01-01
Series:	Linchuang Gandanbing Zazhi
Online Access:	http://www.lcgdbzz.org/qk_content.asp?id=10468

Similar Items

Efficacy of Glucagon-Like Peptide-1 Analogs in Nonalcoholic Fatty Liver Disease: A Systematic Review
by: Teshome G, et al.
Published: (2020-09-01)

Research advances in intestinal flora in nonalcoholic fatty liver disease
by: LIU Jiaqi
Published: (2017-12-01)

Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: An Updated Meta-Analysis of Randomized Controlled Trials
by: Alessandro Mantovani, et al.
Published: (2021-01-01)

Effect of glucagon-like peptide-1 receptor agonists on adipokine level of nonalcoholic fatty liver disease in rats fed high-fat diet
by: Jin Miaomiao, et al.
Published: (2020-07-01)

The serum vitamin D level is inversely correlated with nonalcoholic fatty liver disease
by: Goh Eun Chung, et al.
Published: (2016-03-01)

Effect of fenofibrate on the diversity of intestinal flora in a mouse model of nonalcoholic fatty liver disease
by: ZHANG Dan
Published: (2020-04-01)

Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) for the management of nonalcoholic fatty liver disease (NAFLD): A systematic review
by: Xiaodan Lv, et al.
Published: (2020-07-01)

Analysis of correlation between serum 25-hydroxyvitamin D level and nonalcoholic fatty liver disease
by: CAI Wen, et al.
Published: (2015-07-01)

Changes in intestinal flora in nonalcoholic fatty liver disease: their correlation with insulin resistance index, tumor necrosis factor-α, and interleukin-6
by: ZHANG Qiunan, et al.
Published: (2015-07-01)

Serum homocysteine levels in patients with nonalcoholic fatty liver disease
by: Stergios A. Polyzos, et al.
Published: (2012-01-01)

Correlation of liver fat content with serum vitamin A level and insulin resistance in patients with nonalcoholic fatty liver disease
by: DING Zhiyong
Published: (2017-12-01)

The Acute Regulation of Intestinal Chylomicron Secretion by Glucagon-like Peptides
by: Hsieh, Joanne
Published: (2012)

The Acute Regulation of Intestinal Chylomicron Secretion by Glucagon-like Peptides
by: Hsieh, Joanne
Published: (2012)

Studies into the intestinal growth factor glucagon-like peptide-2
by: Wallis, Katharina
Published: (2009)

Serum visfatin in nonalcoholic fatty liver disease
by: Stergios A. Polyzos, et al.
Published: (2014-01-01)

Serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease
by: Min-Sun Kwak, et al.
Published: (2012-12-01)

Nonalcoholic fatty liver disease and serum uric acid
by: XU Beibei, et al.
Published: (2016-03-01)

Correlation of Serum Transaminase Levels with Liver Fibrosis Assessed by Transient Elastography in Vietnamese Patients with Nonalcoholic Fatty Liver Disease
by: Thong VD, et al.
Published: (2021-04-01)

Detection of cholecystokinin and glucagon like peptide in small intestine of Awassi sheep
by: Huda Shadhan Awadha, et al.
Published: (2017-07-01)

Serum zinc level and hepatic fibrosis in patients with nonalcoholic fatty liver disease.
by: Min Chul Kim, et al.
Published: (2020-01-01)

Elevated serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease
by: Byoung Kuk Jang
Published: (2012-12-01)

Glucagon-Like Peptide-1
by: Joel P. Giblett, BM, BSc, et al.
Published: (2016-06-01)

Serum levels of glucagon-like peptide (GLP)-1 and GLP-2 in patients with Hashimoto′s thyroiditis
by: Yue Jin, et al.
Published: (2015-01-01)

Glucose-induced glucagon-like Peptide 1 secretion is deficient in patients with non-alcoholic fatty liver disease.
by: Christine Bernsmeier, et al.
Published: (2014-01-01)

Fatty liver-induced changes in stereotypic behavior in rats and effects of glucagon-like peptide-1 analog on stereotypy
by: Oytun Erbaş, et al.
Published: (2014-09-01)

Relationship between intestinal microflora imbalance and nonalcoholic fatty liver disease
by: MA Ruijuan
Published: (2015-01-01)

Does Nonalcoholic Pancreatic Steatosis Always Correlate with Nonalcoholic Fatty Liver Disease?
by: Ulasoglu C, et al.
Published: (2021-06-01)

Association between serum preptin level and insulin resistance in patients with nonalcoholic fatty liver disease
by: WANG Jinjun, et al.
Published: (2016-09-01)

Serum levels of adiponectin and ferritin and their clinical significance in patients with nonalcoholic fatty liver in Qinghai, China
by: ZHAO Bin, et al.
Published: (2016-10-01)

Serum Visfatin Levels in Nonalcoholic Fatty Liver Disease and Liver Fibrosis: Systematic Review and Meta-Analysis
by: Abdulrahman Ismaiel, et al.
Published: (2021-07-01)

Effect of Salt Intake on Serum Glucagon-Like Peptide-1 Levels in Normotensive Salt-Sensitive Subjects
by: Wen-Ling Zheng, et al.
Published: (2017-10-01)

Value of serum glucagon like peptide-1 detection in assessment of Alzheimer's disease
by: Dong-Ming Wang, et al.
Published: (2016-02-01)

Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes
by: Seungah Lee, et al.
Published: (2017-03-01)

Role of intestinal mucosal barrier in the development and progression of nonalcoholic fatty liver disease
by: ZHANG Yuanyuan, et al.
Published: (2016-12-01)

Acylation of Glucagon-like peptide-2: interaction with lipid membranes and in vitro intestinal permeability.
by: Sofie Trier, et al.
Published: (2014-01-01)

Enteroendocrine-derived glucagon-like peptide-2 controls intestinal amino acid transport
by: Jennifer Lee, et al.
Published: (2017-03-01)

Glucagon-Like Peptide-1 Receptor Agonist Prevented the Progression of Hepatocellular Carcinoma in a Mouse Model of Nonalcoholic Steatohepatitis
by: Motoyasu Kojima, et al.
Published: (2020-08-01)

Changes in serum asymmetric dimethylarginine levels in progression of liver inflammation in an experimental rat model of nonalcoholic fatty liver disease
by: DING Jie, et al.
Published: (2016-01-01)

A low level of serum total testosterone is independently associated with nonalcoholic fatty liver disease
by: Kim Sunmi, et al.
Published: (2012-06-01)

The Prevalence of Nonalcoholic Fatty Liver Disease and Relationship with Serum Uric Acid Level in Uyghur Population
by: Wen Cai, et al.
Published: (2014-01-01)